Celimmune, LLC is a clinical development-stage immunotherapy company focused on treating and preventing immune-mediated diseases and is headquartered in in Lebanon, New Jersey, and Bethesda, Maryland. Celimmune will initially focus its distinctive core competence in translational medicine, immunotherapy clinical development and commercialization on combating celiac disease and other serious immune-mediated diseases. Celimmune has an exclusive licensing agreement with Amgen to develop, manufacture and commercialize AMG 714, a Phase 2-stage anti-IL-15 monoclonal antibody.
| Website | http://www.celimmune.com |
| Revenue | $6.7 million |
| Employees | View employees |
| Address | 110 Old Driftway Ln, Lebanon, New Jersey 08833, US |
| Phone | +1 908-928-9136 |
| Industry | Internet Service Providers, Website Hosting & Internet-Related Services, Telecommunications |
| Competitors | Amgen, AbbVie, Takeda, Roche, Lilly India, Merck & Co., Inc., Johnson & Johnson, Bristol Myers Squibb, Biogen, Gilead Sciences +48 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 581 Companies, SIC Code 58 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 72 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 722 Companies, NAICS Code 325 Companies |
Looking for a particular Celimmune LLC employee's phone or email?
Celimmune LLC Questions
The Celimmune LLC annual revenue was $6.7 million in 2026.
Celimmune LLC is based in Lebanon, New Jersey.
The NAICS codes for Celimmune LLC are [72, 3254, 32, 722, 325].
The SIC codes for Celimmune LLC are [283, 581, 58, 28].
